Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study

• Published in: Hypertension research Vol. 47; no. 5; pp. 1362 - 1371
• Main Authors: Tezuka, Yuta, Omata, Kei, Ono, Yoshikiyo, Kambara, Kengo, Kamada, Hiroki, Oguro, Sota, Yamazaki, Yuto, Gomez-Sanchez, Celso E., Ito, Akihiro, Sasano, Hironobu, Takase, Kei, Tanaka, Tetsuhiro, Katagiri, Hideki, Satoh, Fumitoshi
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.05.2024; Springer Nature Singapore
• Subjects: Chromatography; Cohort analysis; Enzymes; Immunoassay; Mass spectrometry; Scientific imaging; Confirmatory test; Primary aldosteronism; Chemiluminescent enzyme immunoassay; Captopril challenge test
• ISSN: 0916-9636; 1348-4214; 1348-4214
• DOI: 10.1038/s41440-024-01594-x

The measurement evolution enabled more accurate evaluation of aldosterone production in hypertensive patients. However, the cut-off values for novel assays have been not sufficiently validated. The present study was undertaken to validate the novel chemiluminescent enzyme immunoassay for aldosterone in conjunction with other methods. Moreover, we also aimed to establish a new cut-off value for primary aldosteronism in the captopril challenge test using the novel assay. First, we collected 390 plasma samples, in which aldosterone levels measured using liquid chromatography-mass spectrometry ranged between 0.18 and 1346 ng/dL. The novel chemiluminescent enzyme immunoassay showed identical correlation of plasma aldosterone with liquid chromatography-mass spectrometry, in contrast to conventional radioimmunoassay. Further, we enrolled 299 and 39 patients with primary aldosteronism and essential hypertension, respectively. Plasma aldosterone concentrations measured using the novel assay were lower than those measured by radioimmunoassay, which resulted in decreased aldosterone-to-renin ratios. Subsequently, positive results of the captopril challenge test based on radioimmunoassay turned into “negative” based on the novel assay in 45% patients with primary aldosteronism, using the conventional cut-off value (aldosterone-to-renin activity ratio > 20 ng/dL per ng/mL/h). Receiver operating characteristic curve analysis demonstrated that aldosterone-to-renin activity ratios > 8.2 ng/dL per ng/mL/h in the novel assay was compatible with the conventional diagnosis (sensitivity, 0.874; specificity, 0.980). Our study indicates the great measurement accuracy of the novel chemiluminescent enzyme immunoassay for aldosterone, and the importance of measurement-adjusted cut-offs in the diagnosis of primary aldosteronism.